ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1847

Delayed and Immediate Release Prednisone Decrease Fatigue Comparably in Patients with Systemic Lupus Erythematosus

Hope Rainey1, Kristy Bell1, Violeta Rus2, Daniel Wallace3, Claire Dykas1, Mary Mora1, Maggy Comberg1 and Peter Lipsky1, 1AMPEL BioSolutions LLC., Charlottesville, VA, 2University of Maryland School of Medicine, Baltimore, MD, 3Cedars-Sinai Medical Center/UCLA, Los Angeles, CA

Meeting: ACR Convergence 2020

Keywords: clinical trial, Fatigue, Morning Stiffness, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Session Title: SLE – Treatment Poster II

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Morning stiffness and fatigue are common symptoms in patients with SLE. Increased cytokines and disturbed sleep patterns may contribute to morning symptoms and fatigue in SLE. We, therefore, hypothesized that delayed release (DR) prednisone given in the evening might suppress morning symptoms of stiffness and fatigue better than standard immediate release (IR) prednisone given in the morning.

Methods: This was a multicenter randomized double-blind active comparator double baseline crossover study designed to compare the impact of morning IR prednisone to the same dose of evening DR prednisone in SLE patients with increased fatigue (NCT03098823). Eligible patients met ACR classification of SLE, had a Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) score ≤30 and were prescribed oral IR prednisone at 5-15 mg/day. Patients were randomized in a 1:1 ratio to receive either daily active DR prednisone (RAYOS) at 10pm and daily morning placebo or daily active morning IR prednisone and daily placebo capsules at 10pm at the same total dose they had previously been prescribed. After 3 months, the treatment regimens were reversed, and the patients continued for another 3 months. The primary endpoint was change in fatigue assessed by FACIT-F.

Results: 62 patients were enrolled and randomized and 60 were evaluable for treatment response. At 3 months, there was significant improvement in fatigue measure by FACIT-F, as well as by the Fatigue Severity Score (FSS) and the vitality questions of the SF-36. The mean degree of improvement in fatigue exceeded the minimal clinically important difference (MCID) (see Figures 1 and 2). However, there was no significant difference between the groups in the degree of improvement in fatigue. Following the crossover there was persistent improvement in fatigue compared to baseline, but again no significant difference between the groups. Daily estimates of morning stiffness assessed with a mobile app did not differ between the groups. The frequency of adverse events did not differ between the groups.

Conclusion: DR and IR prednisone were comparable in improving fatigue in patients with SLE. Despite no change in daily prednisone dosage from prescribed doses at entry, fatigue significantly improved, implying that one contributor to fatigue in SLE may be differences between prescribed and actual administered doses of prednisone.


Disclosure: H. Rainey, None; K. Bell, None; V. Rus, None; D. Wallace, None; C. Dykas, None; M. Mora, None; M. Comberg, None; P. Lipsky, Horizon Therapeutics, 3.

To cite this abstract in AMA style:

Rainey H, Bell K, Rus V, Wallace D, Dykas C, Mora M, Comberg M, Lipsky P. Delayed and Immediate Release Prednisone Decrease Fatigue Comparably in Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/delayed-and-immediate-release-prednisone-decrease-fatigue-comparably-in-patients-with-systemic-lupus-erythematosus/. Accessed July 3, 2022.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/delayed-and-immediate-release-prednisone-decrease-fatigue-comparably-in-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies